Bandaram Pharma Faces Profitability Challenges Amid High Debt and Market Adjustments

Mar 19 2025 08:06 AM IST
share
Share Via
Bandaram Pharma Packtech, a microcap in the Medical Equipment sector, has recently experienced an evaluation adjustment reflecting its market position. The company reported flat financial performance for the quarter ending December 2024, with challenges in profitability and a high debt-to-equity ratio, raising concerns about its long-term strength.
Bandaram Pharma Packtech, a microcap company in the Medical Equipment/Supplies/Accessories industry, has recently undergone an evaluation adjustment that reflects its current market standing. The company has reported flat financial performance for the quarter ending December 2024, with an earnings per share (EPS) of Rs -0.01, indicating challenges in profitability.

The company's financial metrics reveal a high debt situation, with a debt-to-equity ratio averaging 2.78 times, which raises concerns about its long-term fundamental strength. Despite this, Bandaram Pharma has managed to achieve a return on equity (ROE) of 8.09%, suggesting limited profitability relative to shareholders' funds. Additionally, the return on capital employed (ROCE) stands at 7.6, which, coupled with an enterprise value to capital employed ratio of 2.4, indicates an attractive valuation.

The technical indicators for Bandaram Pharma have shifted, with the stock now positioned in a mildly bearish range, a change from its previous mildly bullish trend. The Bollinger Band has also shown bearish signals since mid-March 2025.

For those interested in further insights, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News